OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2021
(4)
2022
(3)
2020
(3)
2025
(2)
2026
(1)
2024
(1)
2023
(1)
2017
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth.
Not available
S-EPMC8486041
|
biostudies-literature
Cite
Biomarkers predictive value in early stage non-small cell lung cancer.
Not available
S-EPMC7481621
|
biostudies-literature
Cite
Experimental nonlocality-based network diagnostics of multipartite entangled states.
Not available
S-EPMC5719363
|
biostudies-literature
Cite
Cytopathology practice during the COVID-19 postlockdown: An Italian experience.
Not available
S-EPMC8013362
|
biostudies-literature
Cite
Atlas of PD-L1 for Pathologists: Indications, Scores, Diagnostic Platforms and Reporting Systems.
Not available
S-EPMC9321150
|
biostudies-literature
Cite
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy.
Not available
S-EPMC9369105
|
biostudies-literature
Cite
KRAS
mutations testing in non-small cell lung cancer: the role of Liquid biopsy in the basal setting.
Not available
S-EPMC7399406
|
biostudies-literature
Cite
PET/MRI for staging patients with Hodgkin lymphoma: equivalent results with PET/CT in a prospective trial.
Not available
S-EPMC8116299
|
biostudies-literature
Cite
Pak1 pathway hyper-activation mediates resistance to endocrine therapy and CDK4/6 inhibitors in ER+ breast cancer.
Not available
S-EPMC10232479
|
biostudies-literature
Cite
Expression and prognostic value of FKBP51 in Hodgkin lymphoma
Not available
S-EPMC12620377
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets